deltatrials
Recruiting EARLY_PHASE1 INTERVENTIONAL 2-arm NCT07227883

Secretome Treatment for Facial Rejuvenation

Blinded, Randomized, Controlled, Trial to Evaluate the Efficacy and Safety of Autologous Hair Follicle Secretome for Facial Rejuvenation

Sponsor: Acorn Biolabs Inc.

Conditions Facial Aging Rejuvenation Stem Cell Stem Cell Banking
Interventions Autologous Hair Follicle-Derived Secretome Control Saline
Updated 3 times since 2025 Last updated: Jan 22, 2026 Started: Dec 15, 2025 Primary completion: Dec 20, 2026 Completion: Dec 20, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Facial Aging and Rejuvenation, this trial is actively recruiting participants. The trial is conducted by Acorn Biolabs Inc. and has accumulated 3 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2025 – ~Jan 2026 · 31 days · monthly snapshotNot Yet Recruiting~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

3 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting EARLY_PHASE1

  2. Jan 2026 — Feb 2026 [monthly]

    Recruiting EARLY_PHASE1

    Status: Not Yet Recruiting → Recruiting

  3. Dec 2025 — Jan 2026 [monthly]

    Not Yet Recruiting EARLY_PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Acorn Biolabs Inc.
Data source: Acorn Biolabs Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations